What are the latest advancements in cancer immunotherapy?
Cancer immunotherapy has been a game-changer in the fight against cancer. Recent advancements include the development of CAR-T cell therapy, where a patient's T cells are genetically engineered to attack cancer cells. Additionally, research is focusing on checkpoint inhibitors that target proteins such as PD-1 and CTLA-4, which tumors use to evade the immune system. These therapies have shown promising results in treating various cancers, including melanoma, lung cancer, and certain types of lymphoma.
